Irritable Bowel Syndrome (IBS) continues to be one of the most prevalent and challenging disorders of gut-brain interaction, affecting 5–10% of the population. While dietary and pharmacologic interventions are first-line options, a significant number of patients remain symptomatic, often leaving providers in search of more effective and sustainable solutions.
Clinical hypnosis, and more specifically gut-directed hypnotherapy, is emerging as a powerful tool in managing refractory symptoms, improving patient outcomes, and supporting the brain-gut connection.
What Is Gut-Directed Hypnotherapy?
Gut-directed hypnotherapy (GDH) is a form of evidence-based therapy for GI disorders that specifically targets the communication between the brain and gut. Delivered through structured sessions (typically 8–12), GDH uses clinical hypnosis to calm the enteric nervous system, reduce visceral hypersensitivity, and regulate abnormal GI signaling patterns. It also supports psychological well-being, reducing anxiety and depression commonly comorbid with IBS.
Unlike general relaxation techniques, GDH includes targeted suggestions and imagery designed to shift gut function, making it uniquely suited to address the physiological and emotional components of IBS.
Strong Clinical Evidence Supports Its Use
Clinical hypnosis is among the most rigorously studied behavioral interventions for IBS. More than 35 studies, including 17 randomized controlled trials, consistently show that GDH outperforms control conditions such as waitlists and simple relaxation.
Key findings include:
- Up to 80% of patients report significant symptom improvement in pain, bloating, constipation, and diarrhea.
- Long-term results: Benefits often persist 1–5 years after treatment completion.
- Pediatric effectiveness: Studies confirm GDH is safe and effective for children and adolescents with IBS.
Backed by International Guidelines
GDH is not fringe therapy—it is endorsed by several clinical practice guidelines:
- The American College of Gastroenterology (ACG) and NICE (UK) recommend GDH for IBS patients who do not respond to standard treatment.
- It is supported by European and North American gastroenterology societies as a second-line—and in some cases, first-line—therapy for IBS.
How It Works
GDH operates by modulating the brain-gut axis, targeting multiple key mechanisms, including:
- Reduction in visceral hypersensitivity
- Improvement in maladaptive gut signaling
- Regulation of stress-related GI responses
- Enhanced emotional resilience and reduced GI-specific anxiety
Implementation in Clinical Practice
Gut-directed hypnotherapy is a time-limited and cost-effective intervention typically delivered over 8–12 sessions. It can be offered in person or via telehealth, expanding access for patients across care settings. GDH complements rather than replaces medical management and is currently offered at leading institutions such as Mayo Clinic, Stanford Health Care, Cleveland Clinic, and the VA system.
At GI Psychology, we specialize in providing this advanced level of care to patients with complex GI needs. Our team is trained in clinical hypnosis for IBS and other brain-gut disorders, ensuring that patients receive integrated and expert treatment.
Explore free resources or schedule a free 15-minute phone consultation to learn how evidence-based therapy for GI disorders can help.
References
Black, Christopher J., Peter A. Paine, Anurag Agrawal, Imran Aziz, Maria P. Eugenicos, Lesley A. Houghton, Pali Hungin, et al. 2022. “British Society of Gastroenterology Guidelines on the Management of Functional Dyspepsia.” Gut 71 (9): 1697–1723.
Carla E Flik, Wijnand Laan, Nicolaas P A Zuithoff, Yanda R van Rood, André J P M Smout, Bas L A M Weusten, Peter J Whorwell, Niek J de Wit, Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial, The Lancet Gastroenterology & Hepatology, Volume 4,Issue 1,2019,Pages 20-31,ISSN 2468-1253.
Császár-Nagy, N., and I. Bókkon. 2023. “Hypnotherapy and IBS: Implicit, Long-Term Stress Memory in the ENS?” Heliyon 9 (1): e12751.
Donnet AS, Hasan SS, Whorwell PJ. Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions. Therap Adv Gastroenterol. 2022 Feb 15;15:17562848221074208.
Farrell, Peter, Leslie Farrell, and Michael K. Farrell. 2024. “The Approach to the Management of a Child with Chronic Abdominal Pain.” Current Treatment Options in Pediatrics 10 (2): 64–78.
Gonsalkorale WM, Miller V, Afzal A, Whorwell PJ. Long term benefits of hypnotherapy for irritable bowel syndrome. Gut. 2003 Nov;52(11):1623-9. doi: 10.1136/gut.52.11.1623. PMID: 14570733; PMCID: PMC1773844.
Häuser, Winfried. 2024. “Gut-Directed Hypnosis and Hypnotherapy for Irritable Bowel Syndrome: A Mini-Review.” Frontiers in Psychology 15 (June): 1389911.
Keefer, Laurie, Sarah K. Ballou, Douglas A. Drossman, Gisela Ringstrom, Sigrid Elsenbruch, and Brjánn Ljótsson. 2022. “A Rome Working Team Report on Brain-Gut Behavior Therapies for Disorders of Gut-Brain Interaction.” Gastroenterology 162 (1): 300–315.
Lee HH, Choi YY, , Choi MG. The Efficacy of Hypnotherapy in the Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-analysis. J Neurogastroenterol Motil 2014;20:152-162. https://doi.org/10.5056/jnm.2014.20.2.152
Mayer, Emeran A., Hyo Jin Ryu, and Ravi R. Bhatt. 2023. “The Neurobiology of Irritable Bowel Syndrome.” Molecular Psychiatry 28 (4): 1451–65.
Palsson, Olafur S. 2015. “Hypnosis Treatment of Gastrointestinal Disorders: A Comprehensive Review of the Empirical Evidence.” The American Journal of Clinical Hypnosis 58 (2): 134–58.
Palsson, Olafur S., and Sarah Ballou. 2020. “Hypnosis and Cognitive Behavioral Therapies for the Management of Gastrointestinal Disorders.” Current Gastroenterology Reports 22 (7): 31.
Phillips-Moore, Julie S., Nicholas J. Talley, and Michael P. Jones. 2015. “The Mind-Body Connection in Irritable Bowel Syndrome: A Randomised Controlled Trial of Hypnotherapy as a Treatment.” Health Psychology Open 2 (1): 2055102914564583.
Tan G, Hammond DC, Gurrala J. Hypnosis and irritable bowel syndrome: a review of efficacy and mechanism of action. 2005. In: Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Centre for Reviews and Dissemination (UK).
Vasant, Dipesh H., Syed S. Hasan, Pamela Cruickshanks, and Peter J. Whorwell. 2021. “Gut-Focused Hypnotherapy for Children and Adolescents with Irritable Bowel Syndrome.” Frontline Gastroenterology 12 (7): 570–77.
Webb AN, Kukuruzovic R, Catto‐Smith AG, Sawyer SM. Hypnotherapy for treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD005110. DOI: 10.1002/14651858.CD005110.pub2. Accessed 22 May 2025.